Average Co-Inventor Count = 6.52
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. G.d. Searle & Company (20 from 1,323 patents)
2. Pharmacia Corporation (11 from 200 patents)
3. Other (2 from 832,680 patents)
4. Pharmacia Corporation (of Pfizer, Inc.) (1 from 5 patents)
34 patents:
1. 7420061 - Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors
2. 7138411 - Substituted benzopyran derivatives for the treatment of inflammation
3. 7109211 - Substituted benzopyran derivatives for the treatment of inflammation
4. 6998415 - Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
5. 6951949 - Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
6. 6875785 - Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
7. 6822102 - Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2 mediated disorders
8. 6815460 - Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
9. 6809111 - Prodrugs of COX-2 inhibitors
10. 6806288 - Substituted benzopyran derivatives for the treatment
11. 6753344 - Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
12. 6716991 - Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation
13. 6696477 - Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
14. 6677364 - Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
15. 6613790 - Prodrugs of COX-2 inhibitors